Home > Healthcare > Non-invasive Helicobacter Pylori Testing Market > Table of Contents

Non-invasive Helicobacter Pylori Testing Market - By Test Type (Serologic Test, Urea Breath Test, Stool/Fecal Antigen Test), By Method (Laboratory Based Test, Point of Care (POC) Test), By End-Use (Hospital, Diagnostic Labs) & Forecast, 2024 – 2032

  • Report ID: GMI9134
  • Published Date: Apr 2024
  • Report Format: PDF

Report Content

Chapter 1   Methodology & Scope

1.1    Market scope & definition

1.2    Base estimates & calculations

1.3    Data collection

1.4    Forecast parameters

1.5    Data validation

1.6    Data sources

1.6.1    Primary

1.6.2    Secondary

1.6.2.1    Paid sources

1.6.2.2    Public sources

Chapter 2   Executive Summary

2.1    Industry 3600 synopsis

Chapter 3   Industry Insights

3.1    Industry ecosystem analysis

3.2    Industry impact forces

3.2.1    Growth drivers

3.2.1.1    Rising prevalence of gastric and duodenal illnesses

3.2.1.2    Increasing need for effective anti-microbial treatments

3.2.1.3    Advancements in laboratory serological assay

3.2.1.4    Growing demand for point-of-care testing devices

3.2.2    Industry pitfalls & challenges

3.2.2.1    Strict regulatory regulations and the low detection rate of H. pylori infection

3.3    Growth potential analysis

3.4    Regulatory landscape

3.5    Reimbursement scenario

3.6    Technological landscape

3.7    Porter’s analysis

3.8    PESTEL analysis

3.9    Future market trends

Chapter 4   Competitive Landscape, 2023

4.1    Introduction

4.2    Company matrix analysis

4.3    Competitive analysis of major market players

4.4    Competitive positioning matrix

4.5    Strategy dashboard

Chapter 5   Market Estimates and Forecast, By Test Type, 2021 – 2032 ($ Mn)

5.1    Key trends

5.2    Serologic test

5.3    Urea breath test

5.4    Stool/fecal antigen test

Chapter 6   Market Estimates and Forecast, By Method, 2021 – 2032 ($ Mn)

6.1    Key trends

6.2    Laboratory based test

6.3    Point of care (POC) test

Chapter 7   Market Estimates and Forecast, By End-Use, 2021 – 2032 ($ Mn)

7.1    Key trends

7.2    Hospitals

7.3    Clinics

7.4    Diagnostic laboratories

7.5    Other end users

Chapter 8   Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)

8.1    Key trends

8.2    North America

8.2.1    U.S.

8.2.2    Canada

8.3    Europe

8.3.1    Germany

8.3.2    UK

8.3.3    France

8.3.4    Italy

8.3.5    Spain

8.3.6    Netherlands

8.3.7    Rest of Europe

8.4    Asia Pacific

8.4.1    China

8.4.2    Japan

8.4.3    India

8.4.4    Australia

8.4.5    South Korea

8.4.6    Rest of Asia Pacific

8.5    Latin America

8.5.1    Brazil

8.5.2    Mexico

8.5.3    Argentina

8.5.4    Rest of Latin America

8.6    Middle East and Africa

8.6.1    Saudi Arabia

8.6.2    South Africa

8.6.3    UAE

8.6.4    Rest of Middle East and Africa

Chapter 9   Company Profiles

9.1    Abbott

9.2    Biohit Oyj

9.3    Bio-Rad Laboratories, Inc.

9.4    Cardinal Health

9.5    certest Biotech srl

9.6    Fisher Scientific

9.7    Gulf Coast Scientific

9.8    Meridian Bioscience Inc.

9.9    Quidel Corporation

9.10    Tri-Med
 

Authors: Mariam Faizullabhoy, Gauri Wani

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 10
  • Tables & Figures: 118
  • Countries covered: 23
  • Pages: 105
 Download Free Sample